ASSAF HAROFEH MEDICAL CENTER
🇮🇱Israel
Oxygen as a Limiting Factor for Performing Multitasking
Not Applicable
Completed
- Conditions
- Cognitive Change
- Interventions
- Device: Hyperbaric chamber, normal airDevice: Hyperbaric oxygen
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Assaf-Harofeh Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT03126669
- Locations
- 🇮🇱
Assaf-Harofeh Medical Center, Zerifin, Israel
A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
Phase 2
- Conditions
- Soft-Tissue SarcomaLiposarcoma - Well DifferentiatedLiposarcoma; Mixed TypeLiposarcomas, Dedifferentiated
- Interventions
- First Posted Date
- 2017-03-30
- Last Posted Date
- 2017-10-25
- Lead Sponsor
- Assaf-Harofeh Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT03096912
- Locations
- 🇮🇱
Assaf Harofeh Medical Center, Be'er Ya'aqov, Israel
Impact of Exposure to Environmental Pollutants on Birth Outcomes in an Israeli Cohort
Active, not recruiting
- Conditions
- Exposure to Environmental Pollution
- First Posted Date
- 2017-03-21
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Assaf-Harofeh Medical Center
- Target Recruit Count
- 2394
- Registration Number
- NCT03084445
- Locations
- 🇮🇱
Rambam Medical Center, Haifa, Israel
🇮🇱Lis Medical Center, Tel Aviv, Israel
🇮🇱Assaf Harofeh Medical Center, Zerifin, Israel
Head Out Water Immersion for Hemodynamic Stability During Dialysis
Not Applicable
Completed
- Conditions
- ImmersionIntradialytic Hypotension
- Interventions
- Other: immersionOther: sham session
- First Posted Date
- 2017-02-20
- Last Posted Date
- 2017-04-19
- Lead Sponsor
- Assaf-Harofeh Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT03057392
- Locations
- 🇮🇱
Dialysis Clinic in Asaf Harofhe Medical Center, Zerifin, Israel
A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma
Phase 2
- Conditions
- Soft Tissue SarcomaDesmoplastic Small Round Cell TumorBone SarcomaChondrosarcomaGastrointestinal Stromal SarcomaEwing's Tumor MetastaticEwing's Tumor RecurrentOsteosarcoma
- Interventions
- First Posted Date
- 2016-12-05
- Last Posted Date
- 2017-11-01
- Lead Sponsor
- Assaf-Harofeh Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT02982486
Go For It: to Improve Levels of Daily Physical Activity and to Reduce the Sedentary Life Style of Adolescents With CP
Not Applicable
- Conditions
- Cerebral Palsy (CP)
- First Posted Date
- 2016-12-01
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- Assaf-Harofeh Medical Center
- Target Recruit Count
- 120
- Registration Number
- NCT02978469
The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents
Recruiting
- Conditions
- Growth Hormone DeficiencyIdiopathic Short StatureAttention Deficit Disorder
- Interventions
- Other: Questionnaires
- First Posted Date
- 2016-11-25
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- Assaf-Harofeh Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT02973061
- Locations
- 🇮🇱
Assaf Haroffeh Medical center, Zrifin, Israel
Neurocognitive Performance During Hyperglycemia , and Brain Tissue Integrity in Youth With Type 1 Diabetes and in Healthy
Not Applicable
Active, not recruiting
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Device: MRI including DTI , EEG, CGMSBehavioral: Neurocognitive tests
- First Posted Date
- 2016-10-04
- Last Posted Date
- 2022-07-13
- Lead Sponsor
- Assaf-Harofeh Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT02923323
- Locations
- 🇮🇱
Assaf Haroffeh Medical center, Zerifin, Israel
Association Between Soy Based Formula in Infancy and Puberty
Completed
- Conditions
- Puberty and Body Composition
- Interventions
- Behavioral: soy based formula at infancy
- First Posted Date
- 2016-09-21
- Last Posted Date
- 2020-05-26
- Lead Sponsor
- Assaf-Harofeh Medical Center
- Target Recruit Count
- 98
- Registration Number
- NCT02908971
- Locations
- 🇮🇱
Assaf Haroffeh Medical center, Zerifin, Israel
Angiogenesis Induced in the Elderly by Hyperbaric Oxygen Therapy
Not Applicable
Completed
- Conditions
- Aging
- Interventions
- Device: Hyperbaric Oxygen Therapy
- First Posted Date
- 2016-06-06
- Last Posted Date
- 2020-01-06
- Lead Sponsor
- Assaf-Harofeh Medical Center
- Target Recruit Count
- 62
- Registration Number
- NCT02790541
- Locations
- 🇮🇱
Asaf Harofeh Medical Center, Zerifin, Israel
© Copyright 2025. All Rights Reserved by MedPath